References
- Preiksaitis JK. Indications for the use of cytomegalovirus seronegative blood products. Trans Med Rev 1991;V:1-17.
- Bayer WL, Tegtmeier GE, Barbara JAJ. The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice. Clin Haematol 1984;13:253-69.
- Adler SP. Transfusion-transmitted CMV infection. Clinical importance and means of prevention? Vox Sang 1984;46:387—414.
- Adler SP. Cytomegalovirus and transfusions. Trans Med Rev 1988;II:236-44.
- Gilbert GL, Hayes K, Hudson IL, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Lancet 1989;2:1228-31.
- Adler SP, Lawrence LT, Baggett J, Biro V, Sharp DE. Prevention of transfusion-associated cytomegalovirus infection in very low birth-weight infants using frozen blood and donors seronegative for cytomegalovirus. Transfusion 1984;24:333-5.
- Bowden RA, Sayers M, Fluomoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986;314:1006-10.
- Barbara JAJ, Moulsdale H, Brown S, Griffiths PP, Berry fr’ Contreras M. Modified latex test for anti-cytomegalovirus st; able for pretransfusion screening. J Clin Pathol 1987;40: 115-16.
- Tegtmeier GE. Transfusion-transmitted cytomegalovirus infection: significance and control. Vox Sang 1986;51:22-30.
- McDonald C, Barbara JAJ, Al-Izzi A, Contreras M. Screening plasma donors for high-titre antibody to cytomegalovirus using a latex agglutination test. Vox Sang 1990;59:83-5.